当前位置: X-MOL 学术Clin. Infect. Dis. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients.
Clinical Infectious Diseases ( IF 8.2 ) Pub Date : 2020-04-07 , DOI: 10.1093/cid/ciaa394
Sophie Perinel 1, 2 , Manon Launay 3 , Élisabeth Botelho-Nevers 4 , Éric Diconne 1 , Aurore Louf-Durier 1 , Raphaël Lachand 1 , Martin Murgier 1 , Dominique Page 1 , Régine Vermesch 1 , Guillaume Thierry 1 , Xavier Delavenne 2, 3
Affiliation  

Hydroxychloroquine (HCQ) appears to be a promising treatment for COVID-19. However, all ongoing clinical trials with HCQ use different dosing regimens, resulting on various concentrations PK studies are therefore needed to define the optimal dosing regimen.

中文翻译:

重症监护病房COVID-19患者的羟氯喹剂量优化。

羟氯喹(HCQ)似乎是COVID-19的有前途的治疗方法。但是,所有正在进行的有关HCQ的临床试验均使用不同的给药方案,因此需要对各种浓度的PK研究进行研究,以确定最佳的给药方案。
更新日期:2020-04-08
down
wechat
bug